检索

标题
作者
Impact of the SARS-COV-2 virus on the urinary bladder
Kulchavenya E., Shevchenko S.
Language, cultural adaptation and validation of the OABSS (Overactive Bladder Symptom Score) questionnaire in patients with overactive bladder
Apolikhina I., Teterina T., Arefieva O., Kasyan G., Krivoborodov G., Romikh V., Mirkin Y., Fomenko O., Saidova A., Yarotskaya E., Gorodnova E., Pushkar D., Apolikhin O., Gadzhieva Z., Korshunova E., Filippova E., Kuz'min I., Shornikov P.
Assessment of prescribing practices in overactive bladder pharmacotherapy across different specialties of India: a prescription trend analysis
Krunal V., Sandip S., Hiren P., Madhu S.
Urinary tract infection and overactive bladder. Is there an association?
Gadzhieva Z.
PROSPECTS FOR THE TREATMENT OF IDIOPATHIC AND NEUROGENIC OVERACTIVE BLADDER
Kamalov A., Korshunova E., Popov G., Khodyreva L., Dudareva A., Nizov A.
COMPREHENSIVE PHARMACOLOGIC MANAGEMENT OF OVERACTIVE BLADDER
Krivoborodov G., Tur E.
Flexible approach to the appointment of solifenacin: for whom and when?
Kasyan G.
Nerve growth factor in the urine of patients with idiopathic detrusor overactivity and overactive bladder without detrusor overactivity
Krivoborodov G., Kolesanova E., Tur E., Efremov N.
Overactive bladder: urodynamic characteristics of detrusor overactivity due to the etiology of low urinary tract dysfunction
Philippova E., Bazhenov I., Ziryanov A., Zhuravlev V.
Detrusor ischemia. Clinical effects
Berdichevsky B., Berdichevsky V.
Neurogenic overactive bladder: focus on cognitive function
Korshunova E., Korshunov M., Nuzhnyi E., Zakroyshchikova I., Zabirova A., Korshunov D., Suponeva N., Darenkov S.
New approach to the treatment of patients with overactive bladder. Mirabegron: past, present and future
Korshunova E.
High doses of trospium chloride in patients with idiopathic overactive bladder. Data of large-scale, multicenter observational program “Resource”
Krivoborodov G., Tur E., Efremov N., Shkolnikov M.
IMPERATIVE AND OBSTRUCTIVE URINATION DISORDERS IN PATIENTS WITH CHRONIC INFLAMMATORY DISEASES OF THE URINARY TRACT
Alyaev Y., Gadzhieva Z., Rapoport L., Tsarichenko D., Kazilov Y.
Sexual dysfunction in females with overactive bladder and their correction with M-cholinolytic spasmex
Danilova T., Danilov V., Luchinskiy S., Danilov V., Vasil'chenko A., Danilova T., Danilov V., Luchinsky S., Danilov V., Vasilchenko A.
Lower urinary tract symptoms among women in the Russian Federation: data from an online survey
Pushkar D., Kasyan G., Potapova L., Sukhikh S., Dzhuraeva M.
Pharmacoeconomic analysis of using mirabegron to treat overactive bladder in the setting of the Russian Federation health care
Kolbin A., Vilyum I., Proskurin M., Balykina Y.
Positive effect of increasing dosage of selective antimuscarinics on the main symptoms of overactive bladder
Gadzhieva Z.
OVERACTIVE BLADDER AS A MASK OF CHRONIC PROSTATITIS
Kulchavenya E., Brizhatyuk E., Breusov A.
Bladder microcirculation in females with overactive bladder
Neymark A., Neymark B., Klyzhina E., Batanina I., Neimark A., Neimark B., Klyzhina E., Batanina I.
OVERACTIVE BLADDER - PATHOGENETIC FEATURES AND CHOICE OF DRUG THERAPY
Borisov V.
MIRABEGRON. WHETHER WILL BE A REVOLUTION IN THE PHARMACOTHERAPY OF OVERACTIVE BLADDER?
Romikh V., Borisenko L., Zakharchenko A.
Urination disorders. Do we know all about them?
Gadzhieva Z., Kazilov Y., Alyaev Y., Aboyan I., Kazilov B.
SOLIFENACIN IN THE TREATMENT OF OVERACTIVE BLADDER: RESULTS OF A RANDOMIZED DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
Ibinayeva I., Apolikhina I., Makhmedzhanova F., Muslimova S.
Overactive bladder in patients with infravesical obstruction caused by prostatic adenoma
Alyaev Y., Gadzhieva Z., Petrovskiy N., Alyaev Y., Gadzhieva Z., Petrovsky N.
Urinary disturbances in patients with 142 diabetes
Gadzhieva Z., Atamanova E., Khamidullin K., Pushkarev A.
Validation of urgency scale to detect and assess urgency in patients with overactive bladder
Krivoborodov G., Tur E.
DIAGNOSIS AND TREATMENT OF OVERACTIVE BLADDER SYNDROME IN PELVIC INJURIES
Neymark A., Voytenko A., Bondarenko A., Muzalevskaya N., Kruglykhin I.
Features of neurohumoral regulation in children with combined dysfunction of the pelvic organs
Vishnevsky E., Loran O., Guseva N., Nikitin S.
Combined treatment of patients with prostatic adenoma and overactive bladder
Maksimov V., Khodyreva L., Dudareva A., Al'bitskaya A., Maximov V., Khodyreva L., Dudareva A., Albitskaya A.
Clinicourodynamic rationale of the overactive bladder neurophysiological model
Danilov V., Danilova T., Danilov V., Danilov V., Danilova T., Danilov V.
Epidemiology of urinary disorders in men in the Russian Federation
Korneev I., Alekseeva T., Kogan M., Pushkar' D.
Mirabegron - a new drug for treatment of overactive bladder
Kasjan G.
EFFICIENCY OF TOLTERODINE IN THE TREATMENT OF PATIENTS WITH OVERACTIVE BLADDER
Sayapova D., Sitdykova M.
Effects of synthetic materials used for the treatment of genital prolapse on lower urinary tract function
Kasyan G., Kayfadzhyan M., Malkhasyan V., Pushkar' D., Kasyan G., Kaifadzhan M., Malkhasyan V., Pushkar D.
Surgical correction of overactive bladder resistant to standard therapy
Zuban' O., Lebedev A., Zuban O., Lebedev A.
THE PLACE OF MIRABEGRON IN CLINICAL PRACTICE
Kasyan G., Sukhikh S., Pushkar D.
RATIONALE OF EFFICIENCY AND SAFETY OF USING BETA-3 ADRENERGIC RECEPTOR AGONIST FOR TREATMENT OF OVERACTIVE BLADDER
Gadzhieva Z., Atamanova E.
Prevalence of various voiding disorders
Kazilov Y., Gadzhieva Z.
Distinctive features of vegetative and hormonal regulation in women with overactive bladder syndrome
Kotenko A., Smelysheva L., Kotenko I.
Combined lumbosacral and vaginal physiotherapy in the treatment of overactive bladder in postmenopausal women
Neymark B., Neymark A., Raygorodskiy Y., Tishchenko G., Gol'braykh G., Neimark B., Neimark A., Raigorodsky Y., Tischenko G., Golbraikh G.
Opyt primeneniya trospiya khlorida u bol'nykh s neyrogennoy detruzornoy giperaktivnost'yu
Shvarts P., Kadykov A., Shvedkov V., Timerbaeva S., Polevaya E., Mulach A.
Overactive bladder in the structure of somatized depression
Dorozhenok I., Gadzhieva Z., Ilina E., Bezrukov V.
A role of fesoterodine in treatment of overactive bladder
Kupriyanov Y., Kasyan G., Pushkar D.
Using autonomous electrostimulation device «Erektron» in treating female overactive bladder
Yarin G., Shelyakina O., Fedorenko V., Alekseeva A., Vil’gel’mi I.
PREVALENCE OF URINARY DISORDERS AND THEIR RELATION TO SEXUALITY IN WOMEN - POINT OF VIEW OF GYNECOLOGIST
Makhmedzhanova F., Apolikhina I.
Botulinum toxin type A in patients with overactive bladder
Krivoborodov G., Vasiliev A., Shumilo D., Ivanov A., Tur E.
SAFETY AND EFFICACY OF VESUSTEN® FOR PATIENTS WITH OVERACTIVE BLADDER
Pushkar D., Kupriyanov Y., Gamidov S., Krivoborodov G., Spivak L., Al-Shukri S., Lerman D., Gomberg V., Bogdan E., Shchukin V., Chibirov K., Gelashvili V., Gural A., Keshishchev N., Staroselskaia M., Bastrikova N.
Charasteristics of the treatment of urinary disorders in postmenopausal women
Kulchavenya E., Treyvish L., Baranchukova A.
Imidafenacin for treatment of overactive bladder and urgent urinary incontinence: the results of open-label multicenter randomized controlled clinical trial
Al-Shukri S., Pushkar D., Apolikhin O., Evdokimov M., Kogan M., Krivoborodov G., Kagan O., Petrov S., Poltoratskyi A., Kuzmin I., Sharvadze G.
Features of diagnosis and treatment of various disorders of urination by physicians of the Republic of Dagestan and other regions of the North Caucasus and Southern Federal districts
Gadzhieva Z., Kazilov Y., Alyaev Y., Aboyan I.
Injection of botulinum toxin type a in the bladder detrusor and submucosa in patients with overactive bladder without detrusor overactivity
Krivoborodov G., Tur E., Efremov N.
MODERN APPROACHES TO THE TREATMENT OF PATIENTS WITH OVERACTIVE BLADDER AND URGE URINARY INCONTINENCE
Razdorskaya M., Neimark A., Aliyev R.
Intravesical electrostimulation and magnetophoresis in overactive bladder in females: efficacy of Amus-01-Intramag device with Intrastim attachment
Glybochko P., Aboyan I., Valiev A., Surikov V., Raygorodskiy Y., Glybochko P., Aboyan I., Valiev A., Surikov V., Raigorodsky Y.
Long-term safety and efficacy of trospium chloride for the treatment of neurogenic overactive bladder due to Parkinson's disease - is there an effect on cognitive status?
Korshunova E., Andreev M., Korshunov M., Pyatnitskaya T., Korshunov D., Darenkov S., Suponeva N.
1 - 55 的 55 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回(例如,隐含AND)
  • 使用OR结合多个检索词,便于查找含有这些检索词的文章,例如education OR research
  • 使用括号来创建更复杂的查询; 例如:archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如: "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如:online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语
##common.cookie##